What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His scientific interests lie mostly in Immunology, Mucopolysaccharidosis, Genetic enhancement, Mucopolysaccharidosis VII and Endocrinology.
His biological study spans a wide range of topics, including Factor IX and Bioinformatics.
His work carried out in the field of Mucopolysaccharidosis brings together such families of science as Lysosomal storage disease, Spleen and Central nervous system.
His Genetic enhancement research incorporates elements of Target organ, Gene replacement, Lysosomal storage disorders, Viral vector and Morris water navigation task.
His studies in Mucopolysaccharidosis VII integrate themes in fields like Ratón and Enzyme replacement therapy.
His Endocrinology study integrates concerns from other disciplines, such as Internal medicine and Glucocorticoid receptor.
His most cited work include:
- AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma (438 citations)
- Gene therapy for lysosomal storage diseases. (222 citations)
- Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease (215 citations)
What are the main themes of his work throughout his whole career to date?
Mark S. Sands mainly focuses on Immunology, Lysosomal storage disease, Genetic enhancement, Mucopolysaccharidosis and Pathology.
Mark S. Sands has included themes like Galactosylceramidase, Transplantation, Leukodystrophy and Enzyme replacement therapy in his Immunology study.
In his study, which falls under the umbrella issue of Lysosomal storage disease, Neuronal ceroid lipofuscinosis and Neuroscience is strongly linked to Batten disease.
His Genetic enhancement research includes elements of Adeno-associated virus, Virus, Virology, Central nervous system and Viral vector.
His Mucopolysaccharidosis study incorporates themes from Mucopolysaccharidosis VII, Sly syndrome, Endocrinology and Spleen.
His Pathology research includes themes of Retinal and Anatomy.
He most often published in these fields:
- Immunology (37.50%)
- Lysosomal storage disease (28.98%)
- Genetic enhancement (28.41%)
What were the highlights of his more recent work (between 2012-2021)?
- Immunology (37.50%)
- Lysosomal storage disease (28.98%)
- Enzyme replacement therapy (16.48%)
In recent papers he was focusing on the following fields of study:
Mark S. Sands mostly deals with Immunology, Lysosomal storage disease, Enzyme replacement therapy, Galactosylceramidase and Leukodystrophy.
The study incorporates disciplines such as Genetic enhancement and Transplantation in addition to Immunology.
His Genetic enhancement research is multidisciplinary, incorporating perspectives in Virus, Virology, Adeno-associated virus and Central nervous system.
His Lysosomal storage disease research is multidisciplinary, incorporating perspectives in Batten disease, PPT1 and Infantile neuronal ceroid lipofuscinosis.
His research integrates issues of Immune system, Mucopolysaccharidosis and Pharmacology in his study of Enzyme replacement therapy.
His Mucopolysaccharidosis research incorporates themes from Mucopolysaccharidosis VII, Hepatosplenomegaly and Pediatrics.
Between 2012 and 2021, his most popular works were:
- Clinical course of sly syndrome (mucopolysaccharidosis type VII) (83 citations)
- Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models (69 citations)
- The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors. (63 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Mark S. Sands spends much of his time researching Lysosomal storage disease, Leukodystrophy, Krabbe disease, Galactosylceramidase and Immunology.
His Lysosomal storage disease research includes themes of Batten disease, Enzyme replacement therapy, PPT1 and Infantile neuronal ceroid lipofuscinosis.
The various areas that Mark S. Sands examines in his Enzyme replacement therapy study include Mucopolysaccharidosis VII, Family history, Mucopolysaccharidosis, Hepatosplenomegaly and Pediatrics.
Mark S. Sands interconnects Metabolic disorder and Genetic enhancement in the investigation of issues within Immunology.
His Genetic enhancement research integrates issues from Virus and Virology.
His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
